Soleno Therapeutics, Inc.
(NASDAQ : SLNO)

( )
SLNO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
1.33%104.130.6%$434.28m
ABTAbbott Laboratories
0.86%85.510.8%$411.87m
TMOThermo Fisher Scientific Inc.
1.19%279.441.0%$385.43m
ALGNAlign Technology, Inc.
0.19%177.626.3%$351.79m
ISRGIntuitive Surgical, Inc.
0.01%495.502.4%$292.16m
BDXBecton, Dickinson and Company
1.23%251.381.1%$273.83m
SYKStryker Corporation
0.74%218.601.3%$235.92m
EWEdwards Lifesciences Corporation
1.46%222.541.2%$226.01m
BSXBoston Scientific Corporation
1.38%42.731.1%$214.52m
ZBHZimmer Biomet Holdings, Inc.
1.12%138.541.7%$205.23m
BAXBaxter International Inc.
1.04%87.871.7%$196.71m
ABMDABIOMED, Inc.
-0.36%192.313.3%$158.93m
DXCMDexCom, Inc.
-0.06%163.598.3%$152.97m
WATWaters Corporation
2.10%209.863.8%$119.29m
IDXXIDEXX Laboratories, Inc.
1.50%279.533.7%$112.11m

Company Profile

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It markets CoSense End-Tidal Carbon Monoxide monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns. The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.